Rapid in vitro evolution of flucytosine resistance in Candida auris
ABSTRACT The pan-antifungal-resistant pathogen Candida auris has been causing high-mortality infection outbreaks in hospitals and healthcare settings. The prodrug 5-fluorocytosine (5FC) is one of four chemical entities, but its clinical use as an antifungal drug has been limited owing to pronounced...
Saved in:
| Main Authors: | Trinh Phan-Canh, Duc-Minh Nguyen-Le, Phuc-Loi Luu, Narakorn Khunweeraphong, Karl Kuchler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-04-01
|
| Series: | mSphere |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/msphere.00977-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Octenidine effectively reduces Candida auris colonisation on human skin
by: Diana Cerbu, et al.
Published: (2025-07-01) -
In vitro activities of lipopeptides against fluconazole-resistant Candida auris
by: Simona Fioriti, et al.
Published: (2025-04-01) -
Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections
by: Jie Tu, et al.
Published: (2023-12-01) -
Candida (Candidozyma) Auris: From Colonization to Invasive Disease
by: Burcu AÇIKALIN ARIKAN, et al.
Published: (2025-08-01) -
Risk Factors for Candidozyma auris Among Admitted Patients in Riyadh, Saudi Arabia (2020–2022)
by: Alshahrani FS, et al.
Published: (2025-07-01)